CoChat

Epigenetic mechanisms of rapid-acting antidepressants

Open access
Inserra, Antonio, Campanale, Antonella, Rezai, Tamim, Romualdi, Patrizia, Rubino, Tiziana · 2024 · Translational Psychiatry

The DOI matches its Crossref record; 270 of the 272 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Rapid-acting antidepressants (RAADs), including dissociative anesthetics, psychedelics, and empathogens, elicit rapid and sustained therapeutic improvements in psychiatric disorders by purportedly modulating neuroplasticity, neurotransmission, and immunity. These outcomes may be mediated by, or result in, an acute and/or sustained entrainment of epigenetic processes, which remodel chromatin structure and alter DNA accessibility to regulate gene expression. METHODS: In this perspective, we present an overview of the known mechanisms, knowledge gaps, and future directions surrounding the epigenetic effects of RAADs, with a focus on the regulation of stress-responsive DNA and brain regions, and on the comparison with conventional antidepressants. MAIN BODY: Preliminary correlative evidence indicates that administration of RAADs is accompanied by epigenetic effects which are similar to those elicited by conventional antidepressants. These include changes in DNA methylation, post-translational modifications of histones, and differential regulation of non-coding RNAs in stress-responsive chromatin areas involved in neurotrophism, neurotransmission, and immunomodulation, in stress-responsive brain regions. Whether these epigenetic changes causally contribute to the therapeutic effects of RAADs, are a consequence thereof, or are unrelated, remains unknown. Moreover, the potential cell type-specificity and mechanisms involved are yet to be fully elucidated. Candidate mechanisms include neuronal activity- and serotonin and Tropomyosine Receptor Kinase B (TRKB) signaling-mediated epigenetic changes, and direct interaction with DNA, histones, or chromatin remodeling complexes. CONCLUSION: Correlative evidence suggests that epigenetic changes induced by RAADs accompany therapeutic and side effects, although causation, mechanisms, and cell type-specificity remain largely unknown. Addressing these research gaps may lead to the development of novel neuroepigenetics-based precision therapeutics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-024-03055-y

Cites

270 of 270 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Converging epigenetic mechanisms of rapid-acting and conventional antidepressants. Abbreviations: 5-HTRs, Serotonin Receptors; SIGMAR1, Sigma-1 Receptor; SERT, Serotonin Transporter; NET, Norepinephrine Transporter; TRKB, Tropomyosin Receptor Kinase B; BDNF, Brain-Derived Neurotrophic Factor; NMDA, N-Methyl-D-Aspartate; PLC, Phospholipase C; IP3, Inositol trisphosphate; DAG, Diacylglycerol; MAPK, Mitogen-Activated Protein Kinase; ERK, Extracellular Signal-Regulated Kinase; PI3K, Phosphoinositide 3-Kinase; Akt, AKT Serine/Threonine Kinase 1; PKC, Protein Kinase C; GSK-3, Glycogen Synthase Kinase 3; NF-kB, Nuclear Factor Kappa-B; CaMKs, Calcium Calmodulin Dependent Protein Kinases; Wnt, Proto-Oncogene Wnt-1; JAK, Janus Kinase; STAT, Signal Transducer and Activator of Transcription; PLCγ, Phospholipase C Gamma 1; SSRI, Selective Serotonin Reuptake Inhibitors; SNRI, Serotonin-Norepinephrine Reuptake Inhibitors; MAOI, Monoamine Oxidase Inhibitors; H3, Histone 3; H4, Histone 4; H3K4, Histone 3 Lysine 4; H3K9, Histone 3 Lysine 9; H3K12, Histone 3 Lysine 12; H3K27, Histone 3 Lysine 27; PKA, Protein Kinase A; Mecp2, Methyl-Cpg Binding Protein 2; CREB, cAMP Response Element-Binding Protein; G9a, Histone Methyltransferase G9a; HDAC, Histone Deacetylase; DNMT, DNA Methyltransferase; lncRNA, Long non-Coding RNA; circRNA, Circular RNA; miRNA, micro RNA; NR3C1, Glucocorticoid Receptor; CRH31, Corticotropin Releasing Hormone; PTSD, Post-Traumatic Stress Disorder; LSD, lysergic acid diethylamide.
Fig. 1 Converging epigenetic mechanisms of rapid-acting and conventional antidepressants. Abbreviations: 5-HTRs, Serotonin Receptors; SIGMAR1, Sigma-1 Receptor; SERT, Serotonin Transporter; NET, Norepinephrine Transporter; TRKB, Tropomyosin Receptor Kinase B; BDNF, Brain-Derived Neurotrophic Factor; NMDA, N-Methyl-D-Aspartate; PLC, Phospholipase C; IP3, Inositol trisphosphate; DAG, Diacylglycerol; MAPK, Mitogen-Activated Protein Kinase; ERK, Extracellular Signal-Regulated Kinase; PI3K, Phosphoinositide 3-Kinase; Akt, AKT Serine/Threonine Kinase 1; PKC, Protein Kinase C; GSK-3, Glycogen Synthase Kinase 3; NF-kB, Nuclear Factor Kappa-B; CaMKs, Calcium Calmodulin Dependent Protein Kinases; Wnt, Proto-Oncogene Wnt-1; JAK, Janus Kinase; STAT, Signal Transducer and Activator of Transcription; PLCγ, Phospholipase C Gamma 1; SSRI, Selective Serotonin Reuptake Inhibitors; SNRI, Serotonin-Norepinephrine Reuptake Inhibitors; MAOI, Monoamine Oxidase Inhibitors; H3, Histone 3; H4, Histone 4; H3K4, Histone 3 Lysine 4; H3K9, Histone 3 Lysine 9; H3K12, Histone 3 Lysine 12; H3K27, Histone 3 Lysine 27; PKA, Protein Kinase A; Mecp2, Methyl-Cpg Binding Protein 2; CREB, cAMP Response Element-Binding Protein; G9a, Histone Methyltransferase G9a; HDAC, Histone Deacetylase; DNMT, DNA Methyltransferase; lncRNA, Long non-Coding RNA; circRNA, Circular RNA; miRNA, micro RNA; NR3C1, Glucocorticoid Receptor; CRH31, Corticotropin Releasing Hormone; PTSD, Post-Traumatic Stress Disorder; LSD, lysergic acid diethylamide.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 270 references

Cited by

See all 27

Metadata

Authors
Inserra, A., Campanale, A., Rezai, T., Romualdi, P., & Rubino, T.
Affiliations
  • Universidade do Sul de Santa Catarina (BR)
  • McGill University (CA)
  • University of Bologna (IT)
  • University of Insubria (IT)
Corresponding author
Inserra, Antonio
Venue
Translational Psychiatry
Published
2024-09-04
Volume
14
Issue
1
Pages
359-359
ISSN
2158-3188 (ISSN-L)
OpenAlex
W4402221259
Cited by
27
References
272
Citations by year
2026: 11 · 2025: 14 · 2024: 2
FWCI
1.69
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • IrInSubria (University of Insubria) (submittedVersion)
Funders
  • Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre
  • Fonds de Recherche du Québec-Société et Culture
  • Quebec Autism Research Training Program
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
rapid-acting antidepressants, epigenetics, dissociative anesthetics, psychedelics, DNA methylation, histone modifications, non-coding RNA, neuroplasticity, neurotrophism, serotonin signaling, TrkB signaling, chromatin remodeling, neuroepigenetics, depression treatment
MeSH terms
Animals, Antidepressive Agents, Brain, Histones, Humans, Neuronal Plasticity, Stress, Psychological, DNA Methylation, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epigenetic mechanisms of rapid-acting antidepressants. https://app.cochat.ai/papers/10.1038/s41398-024-03055-y
The paper
Inserra, A., Campanale, A., Rezai, T., Romualdi, P., & Rubino, T. (2024). Epigenetic mechanisms of rapid-acting antidepressants. Translational Psychiatry. https://doi.org/10.1038/s41398-024-03055-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.